PetMed Net Income from 2010 to 2024
| PETS Stock | USD 4.76 0.02 0.42% |
Net Loss | First Reported 2000-03-31 | Previous Quarter 3.8 M | Current Value 2.3 M | Quarterly Volatility 3.2 M |
Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed Express' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.4 M, Interest Expense of 3.6 M or Selling General Administrative of 58 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.14 or PTB Ratio of 0.94. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.
PetMed | Net Income |
Latest PetMed Express' Net Income Growth Pattern
Below is the plot of the Net Income of PetMed Express over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PetMed Express financial statement analysis. It represents the amount of money remaining after all of PetMed Express operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PetMed Express' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (7.46 M) | 10 Years Trend |
|
Net Income |
| Timeline |
PetMed Net Income Regression Statistics
| Arithmetic Mean | 16,068,531 | |
| Coefficient Of Variation | 88.50 | |
| Mean Deviation | 10,718,688 | |
| Median | 17,972,000 | |
| Standard Deviation | 14,221,251 | |
| Sample Variance | 202.2T | |
| Range | 45.2M | |
| R-Value | (0.25) | |
| Mean Square Error | 204.6T | |
| R-Squared | 0.06 | |
| Significance | 0.38 | |
| Slope | (784,325) | |
| Total Sum of Squares | 2831.4T |
PetMed Net Income History
Other Fundumenentals of PetMed Express
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
PetMed Express Net Income component correlations
About PetMed Express Financial Statements
PetMed Express shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may analyze each financial statement separately, they are all interrelated. The changes in PetMed Express' assets and liabilities, for example, are also reflected in the revenues and expenses on on PetMed Express' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -7.5 M | -7.1 M | |
| Net Income Applicable To Common Shares | 267.9 K | 254.6 K | |
| Net Loss | -7.5 M | -7.1 M | |
| Net Loss | (0.37) | (0.35) | |
| Net Income Per E B T | 1.19 | 0.76 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.